This cross-sectional study evaluates COVID-19's long-term impact on corneal transplants in Brazil, indicating a recovery need.
Background and Aims The COVID‐19 pandemic significantly disrupted global eye health services, including corneal transplants. This study evaluates the pandemic's long‐term impact on corneal transplantation across Brazil's five regions, highlighting national and regional recovery trends. Method Monthly corneal transplantation data were obtained from the Brazilian Health Information System (DATASUS) and analyzed across four periods: pre‐pandemic (January 2018 to February 2020), lockdown (March 2020 to December 2020), vaccination (January 2021 to March 2022), and post‐pandemic (April 2022 to June 2024) across the five Brazilian regions. Results Transplants dropped by 54% in 2020, with the South, Northeast, and Southeast most affected. In 2021, as vaccination efforts advanced, transplants recovered by 86%, particularly in the South, Northeast, and Southeast. The upward trend continued in 2022, with an 18% increase nationwide, especially in the North and South. However, in 2023, there was a slight overall decrease of 5%, with declines in the North, Southeast, and Midwest, while the South and Northeast saw minor increases. Conclusion Corneal transplantation in Brazil has shown signs of recovery, but a backlog remains, especially in underserved regions. This study underscores the need for continued monitoring and policy adjustments to address post‐pandemic demand and promote equitable access to eye care.
No takes yet. Share an insight, caveat, or question.
Lessa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Health Science Reports